More patients are being prescribed ADHD medication by GPs in Oxfordshire and surrounding counties, new figures show.
The uptick in prescribing comes amid a shortage of key drugs used to treat the condition.
Attention deficit hyperactivity disorder is a condition which impacts many people across the UK. Adults and children with the condition may have difficulty concentrating, act impulsively and appear restless.
READ MORE: Layla Moran accepts Richard Madeley apology over Gaza
Figures from the NHS Open Prescribing service show 8,226 patients received ADHD medication in the former NHS Buckinghamshire, Oxfordshire and Berkshire West integrated care board area in the three months to June.
This was a rise from 6,532 patients during the same period last year, and a jump of 99 from 4,131 in the spring of 2020.
These figures cover how many patients with an NHS number picked up a prescription during that time frame – accounting for 87 per cent of prescriptions received in the area. In 2020 this covered 90 per cent of prescriptions.
The ADHD Foundation said just over 200,000 (10 per cent) of an estimated 2 million UK citizens with the condition are receiving medication.
Tony Lloyd, chief executive of the charity, said ADHD has been significantly underdiagnosed – particularly among women. He attributes the increase in prescribing to "rebalancing" this underdiagnosis.
However, he added: "Medication should not be used in isolation and should form part of a range of strategies and lifestyle choices to manage ADHD successfully."
The shortages are expected to be resolved between October and December.
In September, the NHS issued a national patient safety alert about a shortage of certain drugs used to treat the condition.
In Buckinghamshire, Oxfordshire and Berkshire, 7,603 patients were prescribed these drugs in some form in the three months to June.
Henry Shelford, chief executive of the ADHD UK charity, said medication is "life-changing" for those with the condition – and taking it away can have disastrous consequences for individuals with ADHD.
He said: "This is devastating for individuals across the country and will be life-changing for some. People with ADHD are being let down by the NHS – this is just the latest way in which we are being failed.”
A spokesman for the Department of Health and Social Care said: "We are aware of supply issues affecting medicines used for the management of ADHD due to increased global demand, and we have issued communications to the NHS to advise healthcare professionals on management of patients during this time.
"We continue to work closely with the respective manufacturers to resolve the issues as soon as possible and to ensure patients have continuous access to ADHD medicines in the UK."
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here